D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.09% |
| 2 | Technology | 10.39% |
| 3 | Financials | 9.94% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Dorian LPG
LPG
$1.94B
| $184K | ﹤0.01% |
19,605
+7,459
| +61% | +$77K |
|
3177
NovaGold Resources
NG
$2.6B
| $184K | ﹤0.01% |
36,569
-412,310
| -92% | -$1.9M |
|
3178
CALL
Trinity Industries
TRN
$2.97B
| $183K | ﹤0.01% |
13,890
-217,101
| -94% | -$3.05M |
|
|
PTX
3179
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $182K | ﹤0.01% |
17,311
-7,353
| -30% | -$146K |
|
3180
CTS Corp
CTS
$1.72B
| $181K | ﹤0.01% |
+11,490
| New | +$172K |
|
|
NPBC
3181
DELISTED
NATL PENN BANCSHARES INC
NPBC
| $180K | ﹤0.01% |
16,935
-39,724
| -70% | -$452K |
|
|
ALPN
3182
DELISTED
Alpine Immune Sciences Inc
ALPN
| $179K | ﹤0.01% |
10,757
+1,787
| +20% | +$35.8K |
|
|
MXWL
3183
DELISTED
Maxwell Technologies Inc
MXWL
| $179K | ﹤0.01% |
30,102
+8,555
| +40% | +$52.4K |
|
3184
NRG Energy
NRG
$29.8B
| $178K | ﹤0.01% |
13,700
+168
| +1% | +$1.92K |
|
|
AFFX
3185
DELISTED
Affymetrix Inc
AFFX
| $178K | ﹤0.01% |
12,672
-80,773
| -86% | -$1.11M |
|
3186
Santander
BSBR
$39.7B
| $176K | ﹤0.01% |
39,432
+7,990
| +25% | +$29.1K |
|
3187
Baytex Energy
BTE
$3.08B
| $176K | ﹤0.01% |
+44,500
| New | +$117K |
|
|
TREC
3188
DELISTED
Trecora Resources
TREC
| $176K | ﹤0.01% |
18,311
+6,388
| +54% | +$64.1K |
|
|
APIC
3189
DELISTED
Apigee Corporation Common Stock
APIC
| $175K | ﹤0.01% |
+21,097
| New | +$157K |
|
3190
Vivani Medical
VANI
$110M
| $172K | ﹤0.01% |
1,480
+514
| +53% | +$59.1K |
|
|
MOMO
3191
Hello Group
MOMO
$869M
| $170K | ﹤0.01% |
15,100
-9,349
| -38% | -$112K |
|
|
PRO
3192
DELISTED
PROS Holdings
PRO
| $170K | ﹤0.01% |
14,417
-11,647
| -45% | -$150K |
|
3193
First Majestic Silver
AG
$8.05B
| $167K | ﹤0.01% |
25,844
-9,855
| -28% | -$42.9K |
|
3194
Myers Industries
MYE
$1.18B
| $167K | ﹤0.01% |
13,024
+2,493
| +24% | +$29.4K |
|
|
NBSE
3195
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $167K | ﹤0.01% |
+130
| New | +$185K |
|
|
ATML
3196
DELISTED
ATMEL CORP
ATML
| $167K | ﹤0.01% |
20,578
-582,620
| -97% | -$4.71M |
|
3197
Alcoa
AA
$11.7B
| $165K | ﹤0.01% |
7,154
-370,399
| -98% | -$7.54M |
|
|
CHK
3198
PUT
DELISTED
Chesapeake Energy Corporation
CHK
| $165K | ﹤0.01% |
200
-3,575
| -95% | -$2.53M |
|
|
CASC
3199
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $163K | ﹤0.01% |
21,326
-32,896
| -61% | -$253K |
|
|
VER
3200
DELISTED
VEREIT, Inc.
VER
| $162K | ﹤0.01% |
3,657
| – | – |
|
Similar funds
D.E. Shaw & Co's Q1 2016 Portfolio in Review
As of Q1 2016, D.E. Shaw & Co held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, D.E. Shaw & Co opened a new position in EQT Corp worth $47.6M.
- D.E. Shaw & Co's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- D.E. Shaw & Co added most to Allergan plc in Q1 2016, an estimated $397M increase.
- D.E. Shaw & Co's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- D.E. Shaw & Co fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- D.E. Shaw & Co opened 382 new positions and closed 773 in Q1 2016.
- D.E. Shaw & Co's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.